查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014432

透析設備市場：依產品類型、治療方法、模式和最終用戶分類－2026-2032年全球市場預測

Dialysis Equipment Market by Product Type, Therapy Type, Modality, End Users - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年透析設備市值為280.2億美元，預計2026年將成長至300.1億美元，複合年成長率為7.33%，到2032年將達到459.8億美元。

主要市場統計數據
基準年 2025 280.2億美元
預計年份：2026年 300.1億美元
預測年份 2032 459.8億美元
複合年成長率 (%) 7.33%

本報告全面概​​述了臨床因素、創新趨勢、監管壓力和戰略重點，所有這些因素共同塑造了現代透析設備市場格局。

透析設備市場正處於臨床需求、技術進步和不斷演變的醫療服務模式的交匯點。慢性腎臟病病率的上升、對以病人為中心的照護日益重視，以及適宜的治療方法向居家環境的轉變，正在重塑醫療設備、耗材和配套基礎設施的需求趨勢和設計重點。同時，流體動力學、血管通路設計、水處理和數位監測平台的進步，使得治療更加安全高效，同時也擴大了透析服務提供者的範圍和地點。

家庭療法的擴展、數位化整合、價值鏈韌性、基於價值的醫療保健獎勵以及永續性考慮，正在推動行業變革。

透析設備產業正經歷由臨床創新、護理模式重組和技術融合所驅動的變革。患者對便利性和降低感染風險的需求，以及對易用性、便攜性和遠端監測功能的日益成長的需求，正在加速居家透析的普及。這項轉變要求製造商優先考慮設備的便攜性、簡化的維護和符合人體工學的設計，以確保患者能夠在醫療機構外安全獨立地使用透析設備。

對 2025 年關稅如何重塑透析設備產業的供應策略、採購實務、產品設計選擇和跨部門合作進行全面評估。

美國將於2025年加徵關稅，這為透析設備相關人員的全球供應鏈、籌資策略和定價考量帶來了新的複雜性。關稅帶來的成本壓力迫使製造商和經銷商重新評估其採購地點，考察替代供應商，並加快關於近岸外包和區域製造中心的討論，以保持競爭力。這些策略性因應措施涉及營運方面的調整，例如重新談判供應商合約、調整庫存政策以及重組物流計劃，以最大限度地降低關稅波動帶來的風險。

主導細分市場，將治療亞型、產品類別、最終用戶環境和治療方法差異與臨床要求、採購因素和產品藍圖選擇連結起來，從而獲得洞察。

要了解市場，需要具備細分觀點臨床實踐模式與產品設計和分銷管道連結起來。根據治療方法類型，市場模式可大致分為血液透析和腹膜透析。血液透析本身可分為傳統血液透析和線上血液透析濾過，這反映了溶質清除策略和系統複雜性的差異。腹膜透析進一步分為自動腹膜透析和持續性攜帶式腹膜透析，每種透析方式在病患訓練、耗材使用和週期計要求方面均有所不同。這些治療方法的差異導致了對設備、耗材和監測解決方案的需求差異，同時也影響臨床路徑和訓練的投入。

關鍵區域資訊揭示了美洲、歐洲、中東和非洲以及亞太市場的需求推動要素、監管差異、基礎設施發展和商業策略。

區域趨勢塑造著不同地理區域的需求促進因素、法律規範和醫療服務模式。在美洲，醫療體系融合了先進的醫療生態系統和多樣化的報銷機制，促進了居家照護和數位化監測的創新，同時高度重視成本控制和供應鏈可靠性。特定市場醫療網路的整合和集中採購為戰略夥伴關係和配套服務協議創造了機遇，這些合作和協議優先考慮總成本和臨床療效。

競爭情報著重於產品組合整合、數位化增強、優質服務和策略聯盟，以此作為在透析設備市場中保持持續主導地位的決定因素。

透析設備產業的競爭動態取決於產品組合的廣度、服務覆蓋範圍、合規性以及硬體和軟體的創新能力。主要企業透過整合解決方案脫穎而出，這些解決方案將可靠的設備和高品質的耗材與強大的售後支援相結合，包括預防性保養計劃、培訓服務和數據驅動的性能最佳化。策略夥伴關係、OEM協議和分銷合作正成為拓展服務覆蓋範圍、覆蓋不同終端用戶群體以及彌合區域服務差距的關鍵機制。

為製造商和供應商提供可操作的策略建議，以使其研發、經營模式和供應鏈韌性與不斷變化的臨床和報銷要求保持一致。

產業領導企業必須採取果斷行動，調整產品開發、商業策略和業務永續營運，以適應重塑透析照護的結構性變革。優先考慮“便於採用的設計”，在確保各種治療亞型臨床療效的同時，兼顧人體工學、簡化維護和直覺的家用介面。投資於能夠提供可操作的營運洞察、實現遠端患者監護並支援基於結果的合約的數位化平台。這些功能可以將設備數據轉化為可衡量的臨床和經濟價值。

對調查方法進行了清晰的概述，詳細介紹了相關人員的參與、二手資訊的檢驗、檢驗協議以及用於得出戰略見解的分析框架。

本執行摘要所依據的研究整合了第一手和第二手資料，從而得出可靠且可操作的結論。第一手資料包括對透析中心、醫院和居家照護項目的臨床醫生、採購經理和技術運營人員進行的結構化訪談，以及與製造和分銷公司高管的討論。這些對話為設備可用性、可維護性、培訓需求和採購決策標準提供了切實可行的觀點。

總結了透析設備產業的策略見解、營運風險和優先行動，以指導經營團隊決策和投資決策。

在對臨床趨勢、技術創新、監管變化和商業性壓力進行全面分析後，透析設備行業的管理人員總結出幾個關鍵的通用見解。首先，以病人為中心的照護模式和居家治療的實現並非邊緣趨勢，而是產品設計和服務需求的核心驅動力。其次，數位化能力的提升正在將設備轉變為平台，從而創造持續創收和與臨床機構更緊密合作的機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 透析設備市場：依產品類型分類

  • 配件
    • 透析椅及透析床
    • 透析器再處理單元
    • 水處理系統
  • 消耗品
    • 血液迴路和裝置
    • 透析液
    • 透析器
    • 靜脈通路裝置
  • 裝置
    • 連續性腎臟替代治療裝置
    • 血液透析機
    • 腹膜透析週期計

第9章 依治療方法分類的透析設備市場

  • 血液透析
    • 傳統血液透析
    • 線上血液透析過濾
  • 腹膜透析
    • 自動化腹膜透析
    • 持續性門診腹膜透析

第10章 透析設備市場：依模式分類

  • 持續治療
    • 連續性腎臟替代療法
    • 持續低效透析
  • 間歇性血液透析

第11章 透析設備市場：依最終用戶分類

  • 透析中心
  • 居家醫療
  • 醫院

第12章 透析設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 透析設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 透析設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國透析設備市場

第16章 中國透析設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AGC Engineering Co., Ltd.
  • Ameridia Innovative Solutions, Inc.
  • ASTOM Corporation
  • Bluestar（Beijing）Chemical Machinery Co., Ltd.
  • C-Tech Innovation Ltd.
  • Electrosynthesis Company, Inc.
  • Entegris, Inc.
  • Eurodia Industrie SA
  • Fujifilm Corporation
  • General Electric Company
  • Ion Exchange（India）Limited
  • JIUWU HI-TECH Co., Ltd.
  • Lenntech BV
  • Mega as
  • PCCell GmbH
  • Pure Water Group
  • Saltworks Technologies Inc.
  • Samco Technologies, Inc.
  • Shandong Tianwei Membrane Technology Co., Ltd.
  • SnowPure, LLC
  • Toray Industries, Inc.
  • Veolia Water Technologies
  • WGM Sistemas SA
  • Xylem Inc.
Product Code: MRR-4348D129FA1E

The Dialysis Equipment Market was valued at USD 28.02 billion in 2025 and is projected to grow to USD 30.01 billion in 2026, with a CAGR of 7.33%, reaching USD 45.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 28.02 billion
Estimated Year [2026] USD 30.01 billion
Forecast Year [2032] USD 45.98 billion
CAGR (%) 7.33%

A comprehensive introduction framing clinical drivers, innovation trends, regulatory pressures, and strategic priorities that collectively define the modern dialysis equipment landscape

The dialysis equipment landscape sits at the intersection of clinical necessity, technological advancement, and evolving care delivery models. Rising prevalence of chronic kidney disease, increasing emphasis on patient-centric care, and the migration of suitable therapies into home settings are collectively reshaping demand signals and design priorities for devices, consumables, and supportive infrastructure. In parallel, advances in fluidics, vascular access design, water treatment, and digital monitoring platforms are enabling safer, more efficient therapies while also broadening the scope of who can deliver dialysis and where it can be delivered.

Healthcare payers and providers are redefining value in renal care, prioritizing outcomes, cost efficiency, and patient experience. This shift is prompting manufacturers to rethink product portfolios, invest in modularity and interoperability, and pursue partnerships that span care delivery, telehealth integration, and home-care enablement. Regulatory environments and quality standards continue to tighten, creating both barriers and opportunities: robust compliance frameworks raise entry thresholds while simultaneously elevating the market value of proven, validated solutions.

The remainder of this executive summary synthesizes these dynamics into strategic implications, segmentation-based insights, regional patterns, competitive observations, and practical recommendations designed to inform decision-makers tasked with navigating rapid change in the dialysis equipment arena.

Transformative industry shifts driven by home therapy growth, digital integration, supply chain resilience, value-based care incentives, and sustainability considerations

The dialysis equipment sector is experiencing transformative shifts driven by clinical innovation, care model reorientation, and technological convergence. Home therapy adoption has accelerated, propelled by patient preference for convenience and infection-risk reduction, alongside improvements in device usability, compactness, and remote monitoring capabilities. This transition requires manufacturers to prioritize portability, simplified maintenance, and clear human factors engineering to enable safe, independent use outside institutional environments.

Concurrently, digital therapeutics and connected device ecosystems are reshaping product expectations. Embedded sensors, predictive maintenance, and cloud-based analytics support preventive interventions and operational efficiencies. These capabilities also create new commercial pathways through software-enabled services, subscription models for consumables, and outcomes-based contracting. Supply chain resilience has moved to the forefront, prompting diversification of sourcing, onshoring where feasible, and strategic stocking to mitigate disruptions.

Value-based care frameworks are incentivizing superior clinical outcomes and cost-effective therapy regimens. Providers are therefore seeking integrated solutions that reduce hospitalization, improve vascular access longevity, and optimize treatment customization. Finally, sustainability concerns are influencing design choices for consumables and water management, with lifecycle thinking increasingly informing procurement and regulatory dialogues. Together, these shifts demand that industry participants adopt more agile, patient-focused, and digitally-enabled product and commercial strategies.

An integrated assessment of how 2025 tariffs have reshaped supply strategies, procurement behavior, product design choices, and cross-functional alignment within the dialysis equipment landscape

The imposition of tariffs in 2025 within the United States has introduced a new layer of complexity for global supply chains, procurement strategies, and pricing considerations for dialysis equipment stakeholders. Tariff-related cost pressures have compelled manufacturers and distributors to revisit sourcing footprints, evaluate alternative suppliers, and accelerate discussions on nearshoring or regional manufacturing hubs to preserve competitive positioning. These strategic responses are accompanied by operational changes including renegotiated supplier contracts, adjusted inventory policies, and restructured logistics planning to minimize exposure to tariff volatility.

Procurement teams within healthcare systems have become more proactive in total-cost-of-ownership assessments, paying closer attention to the cumulative impact of import duties across machines, consumables, and accessories. This scrutiny has led to diversified supplier panels and an increased willingness to enter long-term agreements with manufacturers that can demonstrate supply certainty, quality compliance, and transparent cost structures. In parallel, product design teams are exploring material substitutions and modular architectures that reduce reliance on tariff-affected components without compromising clinical performance.

Clinicians and care managers are adjusting implementation timelines and capital procurement cycles to accommodate new vendor evaluations and pricing negotiations. Payers are observing these shifts and weighing implications for reimbursement policies, particularly where cost increases could threaten access or shift treatment modalities. Overall, the tariff environment has amplified the strategic importance of supply chain agility, vendor partnerships, and cross-functional alignment between commercial, regulatory, and operations teams.

Segmentation-driven insights that map therapy subtypes, product classes, end-user settings, and modality distinctions to clinical requirements, procurement drivers, and product roadmap choices

Understanding the market requires a segmentation-aware lens that links clinical practice patterns to product design and distribution channels. Based on therapy type, the landscape encompasses Hemodialysis and Peritoneal Dialysis. Hemodialysis itself divides into Conventional Hemodialysis and Online Hemodiafiltration, reflecting differences in solute removal strategies and system complexity; Peritoneal Dialysis further separates into Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis, each with distinct patient training, consumable usage, and cycler requirements. These therapy distinctions drive divergent demand for machines, consumables, and monitoring solutions, and they influence clinical pathways and training investments.

Based on product type, the ecosystem includes Accessories, Consumables, and Machines. Accessories span items such as dialysis chairs and beds, dialyzer reprocessing equipment, and water treatment systems that support safe and comfortable therapy delivery. Consumables encompass bloodlines and sets, dialysis fluids, dialyzers, and vascular access devices-components with high clinical sensitivity to material biocompatibility and manufacturing consistency. Machines cover continuous renal replacement therapy devices, hemodialysis machines, and peritoneal dialysis cyclers, each representing different complexity profiles, maintenance demands, and clinical settings of use.

Based on end users, care delivery settings include dialysis centers, home care settings, and hospitals, with each segment imposing unique operational requirements, staff competencies, and procurement channels. Based on modality, therapies are categorized into Continuous Therapies and Intermittent Hemodialysis, where Continuous Therapies include continuous renal replacement therapy and sustained low-efficiency dialysis; modality choices influence machine uptime expectations, consumable consumption patterns, and clinician staffing models. Mapping these segmentation dimensions against clinical outcomes and procurement behavior yields targeted product and go-to-market strategies.

Key regional intelligence that delineates demand drivers, regulatory variation, infrastructure readiness, and commercial tactics across Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics shape demand drivers, regulatory frameworks, and care delivery models across distinct geographies. In the Americas, health systems exhibit a mix of advanced care ecosystems and varying reimbursement landscapes that favor innovation in home therapies and digital monitoring, while also placing premium value on cost containment and supply chain reliability. Health network consolidation and centralized procurement in certain markets create opportunities for strategic partnerships and bundled-service contracts that emphasize total cost and clinical outcomes.

In Europe, Middle East & Africa, heterogeneous regulatory regimes and infrastructure maturity drive differentiated adoption patterns. Western European markets tend to prioritize clinical evidence, sustainability, and integrated care pathways, whereas parts of the Middle East and Africa face infrastructure constraints that prioritize robust, low-maintenance equipment and lifecycle service models. Reimbursement variability across the region necessitates adaptable commercial approaches, including flexible financing and local service partnerships to support market entry and scaled deployment.

In Asia-Pacific, rapid expansion of dialysis access, diverse payer systems, and a strong focus on domestic manufacturing competence present both opportunity and complexity. Demand in the region is influenced by growing urbanization, increasing chronic disease burden, and a competitive supplier landscape that includes both global OEMs and agile local manufacturers. Across these regions, differences in clinical guidelines, vascular access practice, and workforce availability directly affect product specification, training programs, and service models required for successful adoption.

Competitive intelligence that highlights portfolio integration, digital augmentation, service excellence, and strategic alliances as determinants of sustained advantage in dialysis equipment markets

Competitive dynamics in the dialysis equipment sector are shaped by portfolio breadth, service reach, regulatory track record, and the ability to innovate along both hardware and software dimensions. Leading companies differentiate through integrated offerings that combine reliable machines with high-quality consumables and robust post-sale support, including preventive maintenance programs, training services, and data-driven performance optimization. Strategic partnerships, OEM agreements, and distribution alliances have emerged as critical mechanisms to extend reach into diverse end-user segments and to bridge gaps in local service capabilities.

Innovation is not limited to device mechanics; companies that invest in digital platforms, remote monitoring, and telehealth integrations are building recurring-revenue models and deeper clinical ties. At the same time, there is a visible trend toward modular product architectures that simplify upgrades, reduce downtime, and enable component-level sourcing flexibility. Mergers and targeted acquisitions continue to be a strategic lever for accelerating access to complementary technologies, expanding consumables portfolios, and enhancing geographic presence.

Sustained competitive advantage will increasingly depend on cross-functional capabilities: regulatory excellence to accelerate market access, supply chain agility to withstand trade disruptions, clinical evidence generation to support adoption, and commercial models that align with payers' and providers' evolving expectations for value and outcomes.

Actionable strategic recommendations for manufacturers and providers to synchronize R&D, commercial models, and supply chain resilience with evolving clinical and reimbursement imperatives

Industry leaders must move decisively to align product development, commercial strategy, and operational resilience with the structural shifts reshaping dialysis care. Prioritize design-for-adoption that addresses home-use ergonomics, simplified maintenance, and intuitive interfaces while ensuring clinical efficacy across therapy subtypes. Invest in digital platforms that deliver actionable operational insights, enable remote patient monitoring, and support outcomes-based contracting; such capabilities can convert device data into measurable clinical and economic value.

Strengthen supply chain architecture by diversifying sourcing, establishing regional assembly or manufacturing capabilities where feasible, and negotiating flexible contractual terms that allocate tariff and logistics risks in transparent ways. Build service networks and training programs tailored to dialysis centers, hospitals, and home-care providers to reduce operational friction and accelerate clinician confidence. Pursue targeted partnerships and selective acquisitions that complement core capabilities-specifically in consumables, water treatment, or digital services-to create defensible, integrated solutions.

Finally, align engagement with payers and clinical leaders through evidence-generation programs that emphasize patient-centered outcomes, reduced hospitalizations, and cost-effective therapy pathways. This multi-pronged approach will enable organizations to capture emerging opportunities while mitigating regulatory, reimbursement, and supply-side risks.

A clear research methodology overview detailing stakeholder engagement, secondary source triangulation, validation protocols, and analytical frameworks employed to derive strategic insights

The research underpinning this executive summary synthesizes primary and secondary inputs to ensure robust, actionable conclusions. Primary inputs include structured interviews with clinicians, procurement leaders, and technical operations staff across dialysis centers, hospitals, and home-care programs, supplemented by discussions with manufacturing and distribution executives. These engagements provided practical perspectives on device usability, serviceability, training needs, and procurement decision criteria.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance documents, standards for water treatment and device safety, and publicly available technical specifications for machines and consumables. Data validation protocols included cross-referencing respondent statements with technical documentation and service records where available, and triangulating qualitative inputs with observed product features and regulatory filings.

Analytical frameworks applied causal mapping to connect clinical drivers with product requirements, scenario analysis to assess supply chain and tariff impacts, and segmentation matrices to align therapy types, product classes, end users, and modalities with commercial imperatives. Throughout, emphasis was placed on transparency of assumptions, traceability of evidence, and peer review by subject-matter experts to enhance credibility and relevance for executive decision-making.

Concluding synthesis of strategic takeaways, operational risks, and priority actions to guide executive decision-making and investment choices in the dialysis equipment sector

The synthesis of clinical trends, technological innovation, regulatory shifts, and commercial pressures yields several convergent takeaways for executive leaders in the dialysis equipment space. First, patient-centric care models and home therapy enablement are not peripheral trends but central drivers of product design and service requirements. Second, the rise of digital capabilities transforms devices into platforms, creating opportunities for recurring revenue and closer clinical integration.

Third, supply chain shocks and tariff changes underscore the need for resilient sourcing and flexible manufacturing footprints. Fourth, differentiation increasingly depends on integrated offerings that combine reliable hardware, high-quality consumables, and strong post-sale support. Finally, regional heterogeneity demands tailored market-entry strategies that reflect local infrastructure, reimbursement patterns, and clinical practice norms.

Taken together, these insights suggest that organizations that can rapidly adapt product design, commercial models, and operational capabilities to align with clinical realities and payer expectations will be best positioned to succeed. Executives should therefore prioritize cross-functional initiatives that bridge engineering, clinical affairs, supply chain, and commercial teams to translate strategic intent into measurable outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Dialysis Equipment Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Dialysis Chairs And Beds
    • 8.1.2. Dialyzer Reprocessing Equipment
    • 8.1.3. Water Treatment Systems
  • 8.2. Consumables
    • 8.2.1. Bloodlines And Sets
    • 8.2.2. Dialysis Fluids
    • 8.2.3. Dialyzers
    • 8.2.4. Vascular Access Devices
  • 8.3. Machines
    • 8.3.1. Continuous Renal Replacement Therapy Devices
    • 8.3.2. Hemodialysis Machines
    • 8.3.3. Peritoneal Dialysis Cyclers

9. Dialysis Equipment Market, by Therapy Type

  • 9.1. Hemodialysis
    • 9.1.1. Conventional Hemodialysis
    • 9.1.2. Online Hemodiafiltration
  • 9.2. Peritoneal Dialysis
    • 9.2.1. Automated Peritoneal Dialysis
    • 9.2.2. Continuous Ambulatory Peritoneal Dialysis

10. Dialysis Equipment Market, by Modality

  • 10.1. Continuous Therapies
    • 10.1.1. Continuous Renal Replacement Therapy
    • 10.1.2. Sustained Low Efficiency Dialysis
  • 10.2. Intermittent Hemodialysis

11. Dialysis Equipment Market, by End Users

  • 11.1. Dialysis Centers
  • 11.2. Home Care Settings
  • 11.3. Hospitals

12. Dialysis Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Dialysis Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Dialysis Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Dialysis Equipment Market

16. China Dialysis Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AGC Engineering Co., Ltd.
  • 17.6. Ameridia Innovative Solutions, Inc.
  • 17.7. ASTOM Corporation
  • 17.8. Bluestar (Beijing) Chemical Machinery Co., Ltd.
  • 17.9. C-Tech Innovation Ltd.
  • 17.10. Electrosynthesis Company, Inc.
  • 17.11. Entegris, Inc.
  • 17.12. Eurodia Industrie S.A.
  • 17.13. Fujifilm Corporation
  • 17.14. General Electric Company
  • 17.15. Ion Exchange (India) Limited
  • 17.16. JIUWU HI-TECH Co., Ltd.
  • 17.17. Lenntech B.V.
  • 17.18. Mega a.s.
  • 17.19. PCCell GmbH
  • 17.20. Pure Water Group
  • 17.21. Saltworks Technologies Inc.
  • 17.22. Samco Technologies, Inc.
  • 17.23. Shandong Tianwei Membrane Technology Co., Ltd.
  • 17.24. SnowPure, LLC
  • 17.25. Toray Industries, Inc.
  • 17.26. Veolia Water Technologies
  • 17.27. WGM Sistemas S.A.
  • 17.28. Xylem Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIALYSIS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIALYSIS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CHAIRS AND BEDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CHAIRS AND BEDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CHAIRS AND BEDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZER REPROCESSING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZER REPROCESSING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZER REPROCESSING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY WATER TREATMENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY WATER TREATMENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY WATER TREATMENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY BLOODLINES AND SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY BLOODLINES AND SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY BLOODLINES AND SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS FLUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS FLUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS FLUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY VASCULAR ACCESS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY VASCULAR ACCESS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY VASCULAR ACCESS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS CYCLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS CYCLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS CYCLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY SUSTAINED LOW EFFICIENCY DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY SUSTAINED LOW EFFICIENCY DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY SUSTAINED LOW EFFICIENCY DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY INTERMITTENT HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY INTERMITTENT HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY INTERMITTENT HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 194. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 195. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 196. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 199. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 200. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 201. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 224. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 227. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 228. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 229. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 232. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 234. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 235. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 238. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 239. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 240. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 242. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 243. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 245. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)